The ratio of ±KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer

Biochemistry and Cell Biology

Volumn 86, Issue 4, 2008, Pages 312-321

  Yang, Cheng ^a   Romaniuk, Paul J ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Alternative splicing; Intronic enhancer; TIA 1; WT1

Indexed keywords

ACIDS; AMINATION; AMINES; AMINO ACIDS; BINDING ENERGY; CELL DEATH; DIFFERENTIAL AMPLIFIERS; HEALTH; NUCLEIC ACIDS; ORGANIC ACIDS; ZINC;

2-AMINO; ALTERNATIVE SPLICING; APOPTOSIS; DNA BINDING AFFINITY; INTRONIC ENHANCER; ISOFORMS; MUTATIONAL ANALYSIS; NUCLEAR EXTRACTS; PROTEIN-PROTEIN INTERACTIONS; SPLICE SITES; SPLICE VARIANTS; SUBNUCLEAR LOCALIZATIONS; TIA-1; TUMOUR SUPPRESSOR PROTEIN; TUMOUR SUPPRESSORS; WT1; ZINC FINGERS;

TUMORS;

MESSENGER RNA; RNA BINDING PROTEIN; TIA 1 PROTEIN; WT1 PROTEIN; PRIMER DNA;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS LINKING; ENHANCER REGION; FRASIER SYNDROME; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; MUTATIONAL ANALYSIS; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TUMOR SUPPRESSOR GENE; ZINC FINGER MOTIF; CELL LINE; EXON; GENETICS; NUCLEOTIDE SEQUENCE; RNA SPLICING;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENHANCER ELEMENTS, GENETIC; EXONS; HUMANS; INTRONS; MUTAGENESIS, SITE-DIRECTED; RNA SPLICING; RNA, MESSENGER; WT1 PROTEINS;

EID: 49249086609     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O08-075     Document Type: Article

References (41)

1. Balvay, L., Libri, D., Gallego, M., and Fiszman, M.Y. 1992. Intronic sequence with both negative and positive effects on the regulation of alternative transcripts of the chicken β-tropomyosin transcripts. Nucleic Acids Res. 20: 3987-3992. doi:10.1093/nar/20.15.3987. PMID:1508684.
2. Barbaux, S., Niaudet, P., Gubler, M.C., Grunfeld, J.P., Jaubert, F., Kuttenn, F., et al. 1997. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17: 467-470. doi:10.1038/ng1297-467. PMID:9398852.
3. Barbosa, A.S., Hadjiathanasiou, C.G., Theodoridis, C., Papathanasiou, A., Tar, A., Merksz, M., et al. 1999. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum. Mutat. 13: 146-153. doi:10.1002/(SICI)1098-1004(1999)13: 2〈146::AID-HUMU7〉3.0.CO;2-I. PMID:10094551.
4. Bergsdorf, C., Paliga, K., Kreger, S., Masters, C.L., and Beyreuther, K. 2000. Identification of cis-elements regulating exon 15 splicing of the amyloid precursor protein pre-mRNA. J. Biol. Chem. 275: 2046-2056. doi:10.1074/jbc.275.3.2046. PMID:10636908.
5. Borel, F., Barilla, K.C., Hamilton, T.B., Iskandar, M., and Romaniuk, P.J. 1996. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Biochemistry, 35: 12070-12076. doi:10.1021/bi960758o. PMID:8810912.
6. Davies, R.C., Calvio, C., Bratt, E., Larsson, S.H., Lamond, A.I., and Hastie, N.D. 1998. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev. 12: 3217-3225. doi:10.1101/gad.12.20.3217. PMID:9784496.
7. Davies, R.C., Bratt, E., and Hastie, N.D. 2000. Did nucleotides or amino acids drive evolutionary conservation of the WT1 ±KTS alternative splice? Hum. Mol. Genet. 9: 1177-1183. doi:10.1093/hmg/9.8.1177. PMID:10767342.
8. Davies, J.A., Ladomery, M., Hohenstein, P., Michael, L., Shafe, A., Spraggon, L., and Hastie, N. 2004. Development of a si-RNA based method for repressing specific genes in renal organ culture and its use to show that the WT1 tumour suppressor is required for nephron differentiation. Hum. Mol. Genet. 13:235-246. doi:10.1093/hmg/ddh015. PMID:14645201.
9. Del Gatto-Konczak, F., Bourgeois, C.F., Le Guiner, C., Kister, L., Gesnel, M.C., Stévenin, J., and Breathnach, R. 2000. The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. Mol. Cell. Biol. 20: 6287-6299. doi:10.1128/MCB.20.17.6287-6299.2000. PMID:10938105.
10. Dirksen, W.P., Mohamed, S.A., and Fisher, S.A. 2003. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element. J. Biol. Chem. 278: 9722-9732. doi:10.1074/jbc.M207969200. PMID:12509424.
11. Förch, P., and Valcárcel, J. 2001. Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1. Apoptosis, 6: 463-468. doi:10.1023/A:1012441824719. PMID:11595836.
12. Förch, P., Puig, O., Kedersha, N., Martínez, C., Granneman, S., Séraphin, B., et al. 2000. The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol. Cell, 6: 1089-1098. doi:10.1016/S1097-2765(00)00107-6. PMID:11106748.
13. Förch, P., Puig, O., Martínez, C., Sèraphin, B., and Valcárcel, J. 2002. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5́ splice sites. EMBO J. 21: 6882-6892. doi:10.1093/emboj/cdf668. PMID:12486009.
14. Gallego, M.E., Balvay, L., and Brody, E. 1992. cis-Acting sequences involved in exon selection in the chicken β-tropomyosin gene. Mol. Cell. Biol. 12: 5415-5425. PMID:1280322.
15. Gerald, W.L., Rosai, J., and Ladanyi, M. 1995. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc. Natl. Acad. Sci. U.S.A. 92: 1028-1032. doi:10.1073/pnas.92.4.1028. PMID:7862627.
16. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H., and Bruns, G.A.P. 1990. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343: 774-778. doi:10.1038/343774a0. PMID:2154702.
17. Haber, D.A., Buckler, A.J., Glaser, T., Call, K.M., Pelletier, J., Sohn, R.L., et al. 1990. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 61: 1257-1269. doi:10.1016/0092-8674(90)90690-G. PMID:2163761.
18. Haber, D.A., Sohn, R.L., Buckler, A.J., Pelletier, J., Call, K.M., and Housman, D.E. 1991. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. U.S.A. 88: 9618-9622. doi:10.1073/pnas.88.21.9618. PMID: 1658787.
19. Hamilton, T.B., Barilla, K., and Romaniuk, P. 1995. High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res. 23: 277-284. doi:10.1093/nar/23.2.277. PMID:7862533.
20. Hammes, A., Guo, J.K., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., et al. 2001. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell, 106: 319-329. doi:10.1016/S0092-8674(01)00453-6. PMID:11509181.
21. Idelman, G., Glaser, T., Roberts, C.T., and Werner, H. 2003. WT1-p53 interactions in insulin-like growth factor I receptor gene regulation. J. Biol. Chem. 278: 3474-3482. doi:10.1074/jbc.M211606200. PMID:12444079.
22. Izquierdo, J.M., Majós, N., Bonnai, S., Martínez, C., Castelo, R., Guigó, R., et al. 2005. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell, 19: 475-484. doi:10.1016/j.molcel.2005.06.015. PMID: 16109372.
23. Kawai, T., Lal, A., Yang, X., Galban, S., Mazan-Mamczarz, K., and Gorospe, M. 2006. Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR. Mol. Cell. Biol. 26: 3295-3307. doi:10.1128/MCB.26.8.3295- 3307.2006. PMID:16581801.
24. Kikuchi, H., Takata, A., Akasaka, Y., Fukuzawa, R., Yoneyama, H., Kurosawa, Y., et al. 1998. Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? J. Med. Genet. 35: 45-48. PMID:9475094.
25. Klamt, B., Koziell, A., Poulat, F., Wieacker, P., Scambler, P., Berta, P., and Gessler, M. 1998. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 ±KTS splice isoforms. Hum. Mol. Genet. 7: 709-714. doi:10.1093/hmg/7.4.709. PMID:9499425.
26. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D.E., and Jaenisch, R. 1993. WT1 is required for early kidney development. Cell, 74: 679-691. doi:10.1016/0092-8674(93)90515-R. PMID:8395349.
27. Ladomery, M.R., Slight, J., McGhee, S., and Hastie, N.D. 1999. Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein. J. Biol. Chem. 274: 36520-36526. doi:10.1074/jbc.274. 51.36520. PMID:10593950.
28. Larsson, S.H., Charlieu, J.-P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., et al. 1995. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell, 81: 391-401. doi:10.1016/0092-8674(95)90392-5. PMID:7736591.
29. Le Guiner, C., Lejeune, F., Galiana, D., Kister, L., Breathnach, R., Stévenin, J., and Del Gatto-Konczak, F. 2001. TIA-1 and TIAR activate splicing of alternative exons with weak 5′ splice sites followed by a U-rich stretch on their own pre-mRNAs. J. Biol. Chem. 276: 40638-40646. doi:10.1074/jbc.M105642200. PMID:11514562.
30. Li, W., Simarro, M., Kedersha, N., and Anderson, P. 2004. FAST is a survival protein that senses mitochondrial stress and modulates TIA-1-regulated changes in protein expression. Mol. Cell. Biol. 24: 10718-10732. doi:10.1128/MCB.24.24.10718-10732.2004. PMID:15572676.
31. Liu, J.J., Wang, Z.Y., Deuel, T.F., and Xu, Y.H. 1999. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor. Biochem. Biophys. Res. Commun. 254: 197-199. doi:10.1006/bbrc.1998.9897. PMID:9920757.
32. Lovell, M.A., Xie, C., Xiong, L., and Markesbery, W.R. 2003. Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Brain Res. 983: 84-96. doi:10.1016/S0006-8993(03)03032-4. PMID:12914969.
33. Mayo, M.W., Wang, C.-Y., Drouin, S.S., Madrid, L.V., Marshall, A.F., Reed, J.C., et al. 1999. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J. 18: 3990-4003. doi:10.1093/emboj/18.14.3990. PMID:10406804.
34. Murata, Y., Kudoh, T., Sugiyama, H., Toyoshima, K., and Akiyama, T. 1997. The Wilms tumour suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett. 409: 41-45. doi:10.1016/S0014-5793(97)00477-8. PMID: 9199500.
35. Rao, M.K., Pham, J., Imam, J.S., MacLean, J.A., Murali, D., Furuta, Y., et al. 2006. Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. Genes Dev. 20: 147-152. doi:10.1101/gad1367806. PMID:16418481.
36. Reese, M.G., Eeckman, F.H., Kulp, D., and Haussler, D. 1997. Improved splice site detection in Genie. J. Comput. Biol. 4: 311-323. PMID:9278062.
37. Ryan, K.J., and Cooper, T.A. 1996. Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol. Cell. Biol. 16: 4014-4023. PMID:8754799.
38. Shahrabani-Gargir, L., Pandita, T.K., and Werner, H. 2004. Ataxia-telangiectsasis mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1. Endocrinology, 145: 5679-5687. doi:10.1210/en.2004-0613. PMID:15345673.
39. Silberstein, G.B., Van Horn, K., Strickland, P., Roberts, C.T., and Daniel, C.W. 1997. Altered expression of the WT1 Wilms' tumor suppressor gene in human breast cancer. Proc. Natl. Acad. Sci. U.S.A. 94: 8132-8137. doi:10.1073/pnas.94.15.8132. PMID:9223327.
40. Tian, Q., Streuli, M., Saito, H., Schlossman, S.F., and Anderson, P. 1991. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell, 67: 629-639. doi:10.1016/0092-8674(91)90536-8. PMID:1934064.
41. Tian, Q., Taupin, J., Elledge, S., Robertson, M., and Anderson, P. 1995. Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182: 865-874. doi:10.1084/jem.182.3. 865. PMID:7544399.